P

Pfenex Inc

64 employees

Pfenex develops biosimilar therapeutics and novel vaccines for the treatment and prevention of critical human health issues.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Biosimilars
Health Care
reagent proteins
Therapeutics
pseudomonas fluorescens
Process development
Protein Expression
CRM197
Drug Discovery

Date founded

2009

Funding rounds raised

Total raised

$24M

from 1 investors over 1 rounds

P

Pfenex Inc raised $24M on December 9, 2009

Investors: Signet Healthcare Partners

FAQ